Safety Shot
SHOT

$1.01

5.51%

Market Cap: $52.5M

About: Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.

Employees: 8

Materials Perfumes, Cosmetics & Other Toilet Preparations

0

Funds holding %

of 6,686 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

64% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 11

2.68% less ownership

Funds ownership: 12.55% [Q1] → 9.87% (-2.68%) [Q2]

5% less funds holding

Funds holding: 55 [Q1] → 52 (-3) [Q2]

14% less call options, than puts

Call options by funds: $12K | Put options by funds: $14K

33% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 9

52% less capital invested

Capital invested by funds: $12.4M [Q1] → $5.92M (-$6.48M) [Q2]

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for SHOT.

See Analyst Rankings

Financial journalist opinion

Based on 9 articles about SHOT published over the past 30 days

Safety Shot Announces Notice of Allowance for New Patent to Secure IP and Enforce Clinically Backed Claims

New Patent is Added to the Company's Portfolio of Formulations that Rapidly Reduce Blood Alcohol Content JUPITER, Fla. , Sept. 6, 2024 /PRNewswire/ -- Safety Shot, Inc. (Nasdaq: SHOT) ("Safety Shot" or "the Company"), a wellness company behind the world's first rapid alcohol reducer that lowers blood alcohol content ("BAC") by supporting its metabolism in as little as 30 minutes, has announced the Notice of Allowance of for a U.S. patent that covers its newest clinically-backed formula.

Safety Shot Announces Notice of Allowance for New Patent to Secure IP and Enforce Clinically Backed Claims

Safety Shot Announces Notice of Allowance for New Patent to Secure IP and Enforce Clinically Backed Claims

New Patent is Added to the Company's Portfolio of Formulations that Rapidly Reduce Blood Alcohol Content JUPITER, Fla., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Safety Shot , Inc. (Nasdaq: SHOT) (“Safety Shot” or “the Company”), a wellness company behind the world's first rapid alcohol reducer that lowers blood alcohol content (“BAC”) by supporting its metabolism in as little as 30 minutes, has announced the Notice of Allowance of for a U.S. patent that covers its newest clinically-backed formula.

Safety Shot Announces Notice of Allowance for New Patent to Secure IP and Enforce Clinically Backed Claims

Safety Shot President Jordan Schur Invests an Additional $3.4 Million in the Company Through His Family Fund, Core 4 Capital Corp.

JUPITER, Fla. , Sept. 4, 2024 /PRNewswire/ -- Safety Shot, Inc. (Nasdaq: SHOT) (the "Company" or "Safety Shot") is pleased to announce that Safety Shot President Jordan Schur has invested in a $3.4 million private placement in the Company through his family investment group, Core 4 Capital Corp. ("Core 4").

Safety Shot President Jordan Schur Invests an Additional $3.4 Million in the Company Through His Family Fund, Core 4 Capital Corp.

Safety Shot President Jordan Schur Invests an Additional $3.4 Million in the Company Through His Family Fund, Core 4 Capital Corp.

JUPITER, FL, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (the “Company” or “Safety Shot”) is pleased to announce that Safety Shot President Jordan Schur has invested in a $3.4 million private placement in the Company through his family investment group, Core 4 Capital Corp. (“Core 4”).

Safety Shot President Jordan Schur Invests an Additional $3.4 Million in the Company Through His Family Fund, Core 4 Capital Corp.

Safety Shot Clinical Data Results Confirm Breakthrough in Dramatic Reduction of Morning-After Symptoms Associated with Excessive Drinking

The Company Showed a Substantial Reduction in the Physical, Negative Characteristics that Accompany Heavy Drinking in its Recent Groundbreaking, Clinical Study JUPITER, Fla. , Aug. 29, 2024 /PRNewswire/ -- Safety Shot, Inc. (Nasdaq: SHOT) ("Safety Shot" or "the Company"), a wellness company behind the world's first rapid alcohol reducer that lowers blood alcohol content ("BAC") by supporting its metabolism in as little as 30 minutes -- reported another remarkable finding.

Safety Shot Clinical Data Results Confirm Breakthrough in Dramatic Reduction of Morning-After Symptoms Associated with Excessive Drinking

Safety Shot Clinical Data Results Confirm Breakthrough in Dramatic Reduction of Morning-After Symptoms Associated with Excessive Drinking

The Company Showed a Substantial Reduction in the Physical, Negative Characteristics that Accompany Heavy Drinking in its Recent Groundbreaking, Clinical Study

Safety Shot Clinical Data Results Confirm Breakthrough in Dramatic Reduction of Morning-After Symptoms Associated with Excessive Drinking

Safety Shot Announces Partnership with Digital Growth Platform VENDO

As Masters in the E-Commerce Space VENDO is Anticipated to Significantly Help to Grow the Safety Shot Brand Online. JUPITER, Fla.

Safety Shot Announces Partnership with Digital Growth Platform VENDO

Safety Shot Releases Second Quarter 2024 Results and Corporate Highlights

- Q2 Revenues Increased 40% - Q2 Operating Expenses Decreased 17.7% - Recent Clinical Trial Confirms Dramatic Reduction of Blood Alcohol Content - Revolutionary Formula to be Soon Released in Convenient 4-ounce Bottles - Powdered Version of Alcohol-reducing Nutraceutical to be Released in Q4

Safety Shot Releases Second Quarter 2024 Results and Corporate Highlights

Safety Shot Announces Powerful Data Analysis From Recent Clinical Trial Confirming Dramatic Reduction of Blood Alcohol Content

First-of-its-kind wellness company Safety Shot announces clinical trials solidifying the brand's dietary supplement's ability to significantly reduce Blood Alcohol Content JUPITER, Fla. , Aug. 12, 2024 /PRNewswire/ -- Safety Shot, Inc. (Nasdaq: SHOT) (the "Company"), the revolutionary wellness and dietary supplement company dedicated to the promotion of responsible consumption of alcohol, announces significant new findings from a recent clinical trial conducted at The Center for Applied Health Sciences (" CAHS").

Safety Shot Announces Powerful Data Analysis From Recent Clinical Trial Confirming Dramatic Reduction of Blood Alcohol Content

Safety Shot to Release On-the-Go Powder Stick Packs of the World's First Alcohol Reducing Product

With an Expected Launch in Early Q4, Safety Shot Powder Stick Packets Will Address an Anticipated $517M Market Size JUPITER, Fla. , Aug. 5, 2024 /PRNewswire/ -- Safety Shot, Inc. (Nasdaq: SHOT) (the "Company") is pleased to announce that the world's first product to reduce blood alcohol content will soon be available in an on-the-go powder format.

Safety Shot to Release On-the-Go Powder Stick Packs of the World's First Alcohol Reducing Product

See News Rankings